HGF AND TUMOR PROMOTION--A HGF-TRANSGENIC MOUSE MODEL
HGF 与肿瘤促进——HGF 转基因小鼠模型
基本信息
- 批准号:2154936
- 负责人:
- 金额:$ 15.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-12-10 至 1996-11-30
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay biological models cell growth regulation chemical carcinogen chemical carcinogenesis diethylnitrosamine enzyme linked immunosorbent assay gene expression gene induction /repression genetically modified animals growth factor growth factor receptors hyperplasia immunocytochemistry laboratory mouse liver cells liver neoplasms liver regeneration molecular oncology neoplasm /cancer genetics northern blottings oncogenes phenobarbital preneoplastic state protooncogene tissue /cell culture tumor promoters western blottings
项目摘要
Cell proliferation and growth is believed to be necessary for promotion
of tumors and carcinogenesis. In the case of liver, hepatocyte
replication and growth is an essential process during the long period of
progression to cancer. Recently, a potent hepatomitogen (Hepatocyte
Growth Factor, HGF) has emerged as one of the most likely hepatotrophic
agents responsible for maintenance of hepatocyte growth and
proliferation. Despite significant progress in characterizing the
biochemical and biological properties of HGF, the precise physiological
role of this potent epithelial mitogen is unknown in normal and abnormal
cell growth. We have generated several lines of transgenic mice
harboring a human HGF cDNA under the transcriptional control of mouse
Metallothionein 1 promoter. These transgenic animals can provide a
suitable model system to further explore the effects of directed high
expression of HGF in liver tumor promotion and carcinogenesis induced by
different xenobiotics. Utilizing these animals we would like to address
the following questions: A) What are the effects of long term and
continuous expression of HGF in MT1-HGF transgenic mice in the liver and
other tissues? B) Does the chronic overexpression of HGF in MT1-HGF
transgenic mice in conjunction with different liver tumor promoters and
carcinogens lead to enhanced appearance of pre-neoplastic and neoplastic
lesions in the liver of MT1-HGF transgenic mice? C) What are the
molecular signals involved in the induction of HGF gene expression in
regenerating or xenobiotic treated liver in normal or the MT1-HGF
transgenic animals? Answers to these questions may provide further
insight to the molecular mechanisms by which tumor promoters and growth
factors induce chronic cell proliferation and cancer. Employing
techniques and specific molecular probes for HGF detection which are
well-established in our laboratory we will analyze the expression of HGF
and its receptor (the product of proto-oncogene cMET) in the MT1-HGF
transgenic mice treated with or without liver tumor promoters
phenobarbital, ciprofibrate, and the carcinogen Diethylnitrosamine to
determine whether there is any correlation between the high HGF
expression and histopathological abnormalities such as hyperplasia and
neoplasia in these animals. The expression of oncogenes c-myc, c-fos,
and c-jun which are believed to mediate the mitogenic response of several
polypeptide growth factors and also known to be transiently overexpressed
during liver regeneration and in some liver tumors (especially c-myc)
will be investigated in MT1-HGF transgenic and control mice treated with
or without liver tumor promoters. We will also attempt to establish
hepatocyte cell lines derived from the neoplastic and normal livers of
HGF-transgenic mice which may be suitable for in vitro mutagenesis
assays.
据信细胞增殖和生长是促进的必要条件
肿瘤和癌变。 就肝脏而言,肝细胞
复制和增长是长期以来的重要过程
发展为癌症。 最近,有效的肝元素(肝细胞
生长因子,HGF)已成为最有可能的肝营养素之一
负责维持肝细胞生长和
增殖。 尽管在表征
HGF的生化和生物学特性,精确的生理
这种有效的上皮有丝分裂原的作用在正常和异常中尚不清楚
细胞生长。 我们已经生成了几行转基因小鼠
在小鼠的转录控制下携带人类HGF cDNA
金属硫蛋白1启动子。 这些转基因动物可以提供
合适的模型系统,进一步探索了定向高的效果
HGF在肝肿瘤促进和癌变中的表达
不同的异生物学。 利用这些动物我们想解决
以下问题:a)长期的影响和
HGF在肝脏中MT1-HGF转基因小鼠中的连续表达
其他组织? b)MT1-HGF中HGF的慢性过表达
转基因小鼠与不同的肝肿瘤启动子和
致癌物导致肿瘤前和肿瘤的外观增强
MT1-HGF转基因小鼠的肝脏病变? c)什么是
参与HGF基因表达诱导的分子信号
在正常或MT1-HGF中再生或异种生物处理的肝脏治疗
转基因动物? 这些问题的答案可能会进一步提供
洞悉肿瘤启动子和生长的分子机制
因素诱导慢性细胞增殖和癌症。 雇用
HGF检测的技术和特定分子探针
在我们的实验室中建立的良好,我们将分析HGF的表达
MT1-HGF中的受体(原始cmet的乘积)
接受或没有肝肿瘤启动子处理的转基因小鼠
苯巴比妥,电纤维化和致癌二乙基硝基胺至
确定高HGF之间是否存在任何相关性
表达和组织病理学异常,例如增生和
这些动物中的肿瘤。 癌基因c-myc c-fos的表达
据信C-Jun介导了几种有丝分裂的反应
多肽生长因子,也已知瞬时过表达
在肝脏再生和某些肝肿瘤中(尤其是C-MYC)
将在MT1-HGF转基因和对照小鼠中进行研究
或没有肝肿瘤启动子。 我们还将尝试建立
源自肿瘤和正常肝的肝细胞细胞系
可能适合体外诱变的HGF转基因小鼠
测定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Reza Zarnegar其他文献
Reza Zarnegar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Reza Zarnegar', 18)}}的其他基金
Mechanisms of met-Induced Hepatocytes Survival
met 诱导肝细胞存活的机制
- 批准号:
6472032 - 财政年份:2002
- 资助金额:
$ 15.87万 - 项目类别:
相似国自然基金
基于3D生物打印类器官模型探究PAK5调控三阴性乳腺癌铂类耐药的机制研究
- 批准号:82303979
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
构建生物3D打印类器官芯片模型研究弹性蛋白-整合素在胃癌免疫微环境中的作用
- 批准号:32371472
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于微生物群落代谢网络模型构建解析客家黄酒发酵中扣囊复膜酵母与乳酸菌的交互作用机制
- 批准号:32302029
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于三维WSI视觉Transformer模型预测宫颈癌免疫治疗疗效及其生物学机制研究
- 批准号:82303956
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于生物打印技术仿生构建血管化骨组织模型及其骨再生应用研究
- 批准号:32371420
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目